We used a thioacetamide (TAA)-induced intrahepatic cholangiocarcinoma (iCCA) rat model to investigate the DNA vaccine potential against CTLA4, PD-1, and PD-L1. The gene discussed is CTLA4; the disease is infantile convulsions and choreoathetosis.